title: Inhibition of beta-ionone on SGC-7901 cell proliferation and upregulation of metalloproteinases-1 and -2 expression.
abstract: OBJECTIVE
  To observe the effect of beta-ionone on the proliferation of human gastric adenocarcinoma cell line SGC-7901 and the inhibition of metalloproteinase.
  
  
  METHODS
  Using growth inhibition, Zymograms assays and reverse transcription-polymerase-chain reaction (RT-PCR), we examined cell growth rates, activities of matrix metalloproteinases-2 (MMP-2) and -9 (MMP-9), and expression of metalloproteinases-1 (TIMP-1) and -2 (TIMP-2) in SGC-7901 cells after the treatment with beta-ionone for 24 h and 48 h, respectively.
  
  
  RESULTS
  beta-ionone had an inhibitory effect on the growth of SGC-7901 cells. Eight days after the treatment with beta-ionone at concentrations of 25, 50, 100 and 200 micromol/L, the inhibition rates were 25.9%, 28.2%, 74.4% and 90.1%, respectively. The IC50 value of beta-ionone for SGC-7901 cells was estimated to be 89 micromol/L. The effects of beta-ionone on MMP-2 and MMP-9 activities in SGC-7901 cells were not observed. However, the levels of TIMP-1 and TIMP-2 transcripts were elevated in cells treated with beta-ionone in a dose-dependent manner.
  
  
  CONCLUSIONS
  beta-ionone can inhibit the proliferation of SGC-7901 cells, upregulate the expression of TIMP-1 and TIMP-2 expression, and may influence metastasis of cancer.
authors.affiliation: Public Health College, Harbin Medical University, Harbin 150001, Heilongjiang Province, China. jiarl@ems.hrbmu.edu.cn
authors.forename: Jia-Ren
authors.initials: JR
authors.lastname: Liu
authors.forename: Bao-Feng
authors.initials: BF
authors.lastname: Yang
authors.forename: Bing-Qing
authors.initials: BQ
authors.lastname: Chen
authors.forename: Yan-Mei
authors.initials: YM
authors.lastname: Yang
authors.forename: Hong-Wei
authors.initials: HW
authors.lastname: Dong
authors.forename: You-Qiang
authors.initials: YQ
authors.lastname: Song
mesh_terms: D000230:Adenocarcinoma; D002455:Cell Division / Q000187:drug effects; D045744:Cell Line, Tumor / Q000166:cytology / Q000187:drug effects / Q000502:physiology; D006801:Humans; D020781:Matrix Metalloproteinase 1 / Q000378:metabolism*; D020778:Matrix Metalloproteinase 2 / Q000378:metabolism*; D061965:Matrix Metalloproteinase Inhibitors; D045792:Norisoprenoids / Q000494:pharmacology*; D012333:RNA, Messenger / Q000032:analysis; D013274:Stomach Neoplasms; D019715:Tissue Inhibitor of Metalloproteinase-1 / Q000235:genetics; D019716:Tissue Inhibitor of Metalloproteinase-2 / Q000235:genetics; D015854:Up-Regulation / Q000187:drug effects
chemical_list: D061965:Matrix Metalloproteinase Inhibitors; D045792:Norisoprenoids; D012333:RNA, Messenger; D019715:Tissue Inhibitor of Metalloproteinase-1; D019716:Tissue Inhibitor of Metalloproteinase-2; C008157:beta-ionone; D020778:Matrix Metalloproteinase 2; D020781:Matrix Metalloproteinase 1